A Vaccine For Pancreatic Cancer Continues To Show Promise
Pancreatic cancer is notoriously difficult to treat, and about 90% of diagnosed patients die from the disease. A team at Memorial Sloan Kettering has been working to improve those outcomes by developing a new mRNA vaccine for pancreatic cancer. A few years ago, the team embarked on a small trial to test the vaccine’s…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Science Friday →
Cancer vaccines: Empowering the immune system
The extraordinary promise of personalised cancer vaccines
The Evolution Of Cancer Treatment
New Treatment Saves Children With Terminal Brain Cancer
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.